Abstract
Modulation of substance P activity offers a radical new approach to the management of depression, anxiety and stress1,2,3. The substance P receptor is highly expressed in areas of the brain that are implicated in these behaviours, but also in other areas such as the nucleus accumbens which mediate the motivational properties of both natural rewards such as food and of drugs of abuse such as opiates4,5,6,7. Here we show a loss of the rewarding properties of morphine in mice with a genetic disruption of the substance P receptor. The loss was specific to morphine, as both groups of mice responded when cocaine or food were used as rewards. The physical response to opiate withdrawal was also reduced in substance P receptor knockout mice. We conclude that substance P has an important and specific role in mediating the motivational aspects of opiates and may represent a new pharmacological route for the control of drug abuse.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 51 print issues and online access
$199.00 per year
only $3.90 per issue
Buy this article
- Purchase on SpringerLink
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
De Felipe, C. et al. Altered nociception, analgesia and aggression in mice lacking the receptor for substance P. Nature 392, 394–397 (1998).
Kramer, M. S. et al. Distinct mechanism for antidepressant activity by blockade of central substance P receptors. Science 281, 1640–1645 (1998).
Culman, J., Klee, S., Ohlendorf, C. & Unger, T. Effect of tachykinin receptor inhibition in the brain on cardiovascular and behavioural responses to stress. J. Pharmacol. Exp. Ther. 280, 238–246 (1997).
Nakaya, Y. et al. Immunohistochemical localization of substance P receptor in the central nervous system of the adult rat. J. Comp. Neurol. 347, 249–274 (1994).
Wise, R. A. Neurobiology of addiction. Curr. Opin. Neurobiol. 6 , 243–251 (1996).
Robbins, T. W. & Everitt, B. J. Drug addiction: bad habits add up. Nature 398, 567–570 (1999).
Koob, G. F., Sanna, P. P. & Bloom, F. E. Neuroscience of addiction. Neuron 21, 467–476 (1998).
Koob, G. K. & Le Moal, M. Drug abuse: Hedonic homeostatic dysregulation. Science 278, 52– 70 (1997).
Gerfen, C. R. Substance P (neurokinin-I) receptor mRNA is selectively expressed in cholinergic neurons in the striatum and basal forebrain. Brain Res. 556, 165–170 (1991).
Maldonado, R. et al. Absence of opiate rewarding effects in mice lacking dopamine D2 receptors. Nature 388, 586– 589 (1995).
Baik, J. H. et al. Parkinsonian-like locomotor impairment in mice lacking dopamine D2 receptors. Nature 377, 424– 428 (1995).
Wise, R. A. & Bozarth, M. A. A psychomotor stimulant theory of addiction. Psychol. Rev. 97, 469– 492 (1987).
Bechara, A. & van der Kooy, D. A single brain stem substrate mediates the motivational effects of both opiates and food in nondeprived rats but not in deprived rats. Behav. Neurosci. 106 , 351–363 (1992).
Maldonado, R., Girdlestone, D. & Roques, B. P. RP 67580, a selective antagonist of neurokinin-1 receptors, modifies some of the naloxone-precipitated morphine withdrawal signs in rats. Neurosci. Lett. 156, 135– 140 (1993).
Matthes, H. W. D. et al. Loss of morphine-induced analgesia, reward effect and withdrawal symptoms in mice lacking the m-opioid-receptor gene. Nature 383, 819–823 (1996).
Rupniak, N. M. J. et al. A Pharmacological blockade or genetic deletion of substance P (NK1) receptors attenuates neonatal vocalisation in guinea-pigs and mice. Neuropharmacology (in the press).
Maldonado, R., Stimus, L., Gold, L. & Koob, G. F. Role of different brain structures in the expression of the physical morphine withdrawal syndrome. J. Pharmacol. Exp. Ther. 261, 669– 677 (1992).
Bozarth, M. A. Physical dependence produced by central morphine infusions: an anatomical mapping study. Neurosci. Biobehav. Rev. 18, 373–383 (1994).
Mansour, A., Fox, C. A., Burke, S., Akil, H. & Watson, S. J. Immunohistochemical localization of the cloned mu opioid receptor in the rat CNS. J. Chem. Neuroanat. 8, 283–305 (1995).
Kieffer, B. L., Beford, K., Gaveriaux-Ruff, C. & Hirth, C. G. The delta-opioid receptor: isolation of a cDNA by expression cloning and pharmacological characterization. Proc. Natl Acad. Sci. USA 89, 12048–12052 (1992).
Izenwasser, S., Buzas, B. & Cox, B. M. Differential regulation of adenylyl cyclase activity by mu and delta opioids in rat caudate putamen and nucleus accumbens. J. Pharmacol. Exp. Ther. 267, 145– 152 (1993).
Nye, H. E. & Nestler, E. J. Induction of chronic Fos-related antigens in rat brain by chronic morphine administration. Mol. Pharmacol. 49, 636–645 ( 1996).
Kelz, M. B. et al. Expression of the transcription factor delta FosB in the brain controls sensitivity to cocaine. Nature 401, 272–276 (1999).
Aubry, J. M., Schulz, M. F., Pagliusi, S., Schulz, P. & Kiss, J. Z. Coexpression of dopamine D2 and substance P (neurokinin-1) receptor messenger RNAs by a subpopulation of cholinergic neurons in the rat striatum. Neuroscience 53, 417–424 (1993).
Graybiel, A. M., Aosaki, T., Flaherty, A. W. & Kimura, M. The basal ganglia and adaptive motor control. Science 265, 1826–1831 (1994).
Elliott, P. J. & Iversen, S. D. Behavioural effects of tachykinins and related peptides. Brain Res. 381, 68–76 (1986).
Boix, F., Sandor, P., Nogueira, P. J., Huston, J. P. & Schwarting, R. K. Relationship between dopamine release in nucleus accumbens and place preference induced by substance P injected into the nucleus basalis magnocellularis region. Neuroscience 64, 1054–1055 (1995).
Shaham, Y. & Stewart, J. Stress reinstates heroin-seeking in drug-free animals: an effect mimicking heroin, not withdrawal. Psychopharmacol. 119, 334–341 (1995).
Acknowledgements
We thank J. O'Brien, J. A. Perez De Gracia, and P. Mantyh, R. Maldonado and C. Stanford for reading and commenting on the manuscript, and N. Rupriak for sharing unpublished data.
Author information
Authors and Affiliations
Corresponding author
Supplementary information
41586_2000_BF35012069_MOESM1_ESM.doc
Table 1: Incidence of behavioural signs of abstinence measured during naloxone-precipitated morphine withdrawal syndrome in wild and NK1 -/- mice. (DOC 24 kb)
Rights and permissions
About this article
Cite this article
Murtra, P., Sheasby, A., Hunt, S. et al. Rewarding effects of opiates are absent in mice lacking the receptor for substance P. Nature 405, 180–183 (2000). https://doi.org/10.1038/35012069
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1038/35012069
This article is cited by
-
Evaluation of tradipitant, a selective NK1 antagonist, on response to oxycodone in humans
Psychopharmacology (2021)
-
Circuits and functions of the lateral habenula in health and in disease
Nature Reviews Neuroscience (2020)
-
Genetic and pharmacological antagonism of NK1 receptor prevents opiate abuse potential
Molecular Psychiatry (2018)
-
Modeling anorexia nervosa: transcriptional insights from human iPSC-derived neurons
Translational Psychiatry (2017)
-
Differential effects of aprepitant, a clinically used neurokinin-1 receptor antagonist on the expression of conditioned psychostimulant versus opioid reward
Psychopharmacology (2017)